These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
775 related articles for article (PubMed ID: 28652891)
1. Non-alcoholic fatty liver disease: An expanded review. Benedict M; Zhang X World J Hepatol; 2017 Jun; 9(16):715-732. PubMed ID: 28652891 [TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease - current status and future directions. Demir M; Lang S; Steffen HM J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351 [TBL] [Abstract][Full Text] [Related]
3. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Vernon G; Baranova A; Younossi ZM Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852 [TBL] [Abstract][Full Text] [Related]
4. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications. Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007 [TBL] [Abstract][Full Text] [Related]
5. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease. Kalogirou MS; Giouleme O World J Transplant; 2022 Sep; 12(9):281-287. PubMed ID: 36187880 [TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease: The diagnosis and management. Abd El-Kader SM; El-Den Ashmawy EM World J Hepatol; 2015 Apr; 7(6):846-58. PubMed ID: 25937862 [TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Gerges SH; Wahdan SA; Elsherbiny DA; El-Demerdash E Life Sci; 2021 Apr; 271():119220. PubMed ID: 33592199 [TBL] [Abstract][Full Text] [Related]
10. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD). Johnston MP; Patel J; Byrne CD Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662 [TBL] [Abstract][Full Text] [Related]
11. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986 [TBL] [Abstract][Full Text] [Related]
12. Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer. Wang K; Wei Y; Xu R; Li Y; Mao C Adv Exp Med Biol; 2022; 1372():157-168. PubMed ID: 35503180 [TBL] [Abstract][Full Text] [Related]